REFERENCES
- Smith SSG, Karayalcin G, Bonagura V. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy. J Pediatr. 1995;127:68–75.
- Spickermann D, Gause A, Pfreundschuh M, Impaired antibody levels to tetanus toxoid and pneumococcal polysaccharides in acute leukemias. Leuk Lymphoma. 1994;16:89–96.
- Alanko SPT, Salmi TT. Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer. 1992;69:1481–1486.
- Avigan DPL, Lazarus HM. Vaccination against infectious disease following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:171–183.
- Henning KJ, White MH, Sepkowitz KA, Armstrong D. A national survey of immunization practices following allogeneic bone marrow transplantation. JAMA. 1997;277:1148–1151. 1997;277:1148–1151.
- Parkkali T, Olander RM, Ruutu T, A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant. 1997;19:933–938.
- Ljungman P, Cordonnier C, Einsele H, Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009;44:521–526.
- van Tilburg CM, Sanders EA, Rovers MM, Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia. 2006;20:1717–1722.
- Ercan TE, Soycan LY, Apak H, Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005;27:273–277.
- de Vaan GA, van Munster PJ, Bakkeren JA. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia of childhood. Eur J Pediatr. 1982;132:113–117.
- Kung FH, Orgel HA, Wallace WW, Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease. Pediatrics. 1984;74:86–89.
- Nyerges G, Zimonyi I, Nyerges G, Efficiency of tetanus toxoid booster in leukemic children. Acta Paediatr Acad Sci Hung. 1981;67:222–229.
- Ridgway D, Wolff LJ, Deforest A. Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child. 1991;145:887–891.
- Nilsson A, De Milito A, Engström P, Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics. 2002;109:e91.
- Feldman S, Andrew M, Norris M, Decline in rates of seropositivity for measles, mumps and rubella antibodies among previously immunized children treated for acute leukemia. Clin Infect Dis. 1998;27:388–390.
- Zignol M, Peracchi M, Tridello G, Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004;101:635–641.
- Lehrnbecher T, Schubert R, Allwinn R, Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules. Br J Haematol. 2011;152:754–757.
- Kantar M, Cetingül N, Kansoy S, Immune deficiencies following cancer treatment in children. J Trop Pediatr. 2003;49:286–290.
- van der Does-van den Berg A, Hermans J, Nagel J, Immunity to diphtheria, pertussis, tetanus and poliomyelitis in children with acute lymphoblastic leukemia after cessation of chemotherapy. Pediatrics. 1981;67:222–229.
- Calaminus G, Hense B, Laws HJ, Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92. Klin Padiatr. 2007;219:355–360.
- Aytac S, Yalcin SS, Cetin M, Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2010;27:333–343.